This is an Open Access article distributed under the terms of the creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Introduction: Transcatheter aortic valve implantation (TAVI) is now considered as an alternative treatment option for severe aortic stenosis (AS) patients who cannot undergo surgical aortic valve replacement (AVR). Case report: We describe the first Korean case of transaortic TAVI with mini-sternotomy using CoreValve. A 83-year-old woman with severe AS and recent history of non-ST elevation myocardial infarction was referred to our institution for TAVI intervention. There was no amenable peripheral vascular access for transfemoral or trans-subclavian approach. Considering the relatively high procedural risk of transapical approach in this patient, we performed transaortic TAVI with mini-sternotomy.
INTRODUCTION
Surgical aortic valve replacement (AVR) is the treatment of choice of symptomatic severe aortic stenosis (AS). With technological advancements, an alternative to surgical AVR, transcatheter aortic valve implantation (TAVI) has recently emerged and has been performed widely after the first case a decade ago. 1, 2 The most common route used to deliver transcatheter aortic valve is femoral artery.
For patients with significant peripheral arterial diseases, especially common femoral or iliac artery stenosis, other access approach such as transapical or trans-subclavian approach can be considered. For whom with unsuitable conditions for previously mentioned routes, direct transaortic access with a mini-sternotomy could be an alternative option. In this case report, we describe the first Korean case of trans-aortic TAVI using CoreValve (Medtronic) for an 83-year-old woman. wire was inserted over the pigtail and placed into the left ventricle. Thereafter, the 6F vascular sheath was exchanged for a 18F sheath (Fig. 3B) . After the aortic valve was predilated with a 18 mm balloon (Z-med, NuMED www.lipid.or.kr findings between before the procedure and after that (Fig. 5) . She recovered fully without any adverse event and was discharged on the 9th day after the procedure.
The patient is currently being followed for 18 months without significant adverse cardiovascular event. Commonly, TAVI procedure is performed via femoral artery because its diameter is generally more than 6 mm so that 18F device introducer sheath and delivery catheter can be introduced. Small size common femoral or iliac arteries are contraindicated for a transfemoral approach.
DISCUSSION
There is an increased risk of iliac rupture which can result in fatality, when forceful delivery of a large sheath attempted in small iliac arteries. In such cases, transaortic or trans-subclavian approach is generally recommended.
Thus, when bilateral iliofemoral arteries are not eligible due to concomitant peripheral artery disease, alternative routes such as trans-subclavian, transapical, or direct aortic access through mini-thoracotomy/sternotomy could be considered. In our case, trans-subclavian approach was not amenable due to small diameter of subclavian artery.
Transapical approach is not feasible with CoreValve system. Furthermore, transapical approach is known to associated with the mortality from LV apical tear or rupture at the site of puncture, 3 and has also complications including LV apical false aneurysm, arrhythmias, and echocardiographic hypokinesia or akinesia of the LV apex. [4] [5] [6] With recent experiences, there were no significant differences in 30 day mortality or procedural complications between transapical approach and transaortic approach. 7 In another study, potential advantages including ease of access and procedure related complication (e.g. false aneurysm, wound pain, respiratory dysfunction) compared with transapical approach were suggested. 8 Direct aortic access can be obtained by mini-sternotomy as well as with a right anterior mini-thoracotomy. 9 The direct aortic approach has advantage of overcoming challenging vascular disease, and avoids the risk of dislodging atherosclerotic plaque during procedure through the aorta that may cause distal embolism and subsequent stroke. 9 Cannula access is technically easy and hemorrhage or late pseudoaneurysm risk is relatively low. 8 Our patient tolerated wound pain very well and showed early respiratory and physical recovery without any adverse event. To our knowledge, this was the first case of successful transaortic TAVI in Korea.
In conclusion, an 83-year-old female patient without proper femoral or subclavian artery access successfully underwent trans-aortic TAVI via mini-sternotomy. This case suggests transaortic approach may be an effective and safe strategy for TAVI in high risk severe AS patients without eligible femoral or subclavian access routes.
